Navigation Links
Lycera Closes $36 Million Series A Financing
Date:4/16/2009

ANN ARBOR, Mich., April 16 /PRNewswire/ -- Lycera Corp. today announced it has closed a $36 million Series A financing.

The company, which is developing novel small-molecule pharmaceuticals to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, has received $10 million as a first tranche of the financing and will receive the remainder of the proceeds in two tranches as specific milestones are met. InterWest Partners, ARCH Venture Partners and Clarus Ventures co-led the financing. EDF Ventures, which led a seed financing in November 2006, is also participating.

In conjunction with the closing, Jeffrey Leiden, M.D., Ph.D., a managing director with Clarus; Kristina Burow, a partner with ARCH; and Nina Kjellson, a general partner with InterWest, have joined Lycera's board of directors. These additions have increased board membership to six. Steven Gillis, Ph.D., a managing director with ARCH, and Mary Campbell, a managing director at EDF Ventures, will serve as board observers.

Lycera also announced that it has expanded its development initiatives for small-molecule immunomodulators through the addition of a program targeting the Th17 pathway discovered by Dan Littman, M.D., Ph.D. Dr. Littman, the Helen L. and Martin S. Kimmel professor of molecular immunology and professor of pathology and microbiology at the Skirball Institute of Biomolecular Medicine of New York University School of Medicine, an investigator of the Howard Hughes Medical Institute, and a member of the National Academy of Sciences, will serve as chairman of the company's scientific advisory board.

"This financing round is an important validation of the Lycera technology platforms," said Dr. Gary Glick, Lycera's founder and chief scientific officer. "The company is fortunate to be working with a distinguished, talented and experienced group of investors. Their expertise in the dis
'/>"/>

SOURCE Lycera Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
2. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
3. Cell Biosciences Closes $10 Million Series C Financing
4. Index Ventures Closes Euro 350 Million Early Stage Fund
5. Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm
6. Opsona Therapeutics Closes EUR18M Funding
7. iCo Therapeutics Closes $1.3 Million Private Placement
8. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
9. Lytix Closes USD 10.4 Million Funding Round
10. Singulex Closes $19 Million Financing Round
11. Karolinska Development Closes Fully Subscribed New Share Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... India’s vast and growing population means ... up to a billion dollars per year by ... taking serious action to better regulate and oversee ... will examine:, ,     Recent changes in ... long term impacts ,     Foreseeable opportunities ...
(Date:6/19/2013)... 18, 2013 A new look at ... and other trends will highlight technical sessions at ... fall. In its 33rd year, the three-day event is ... of key suppliers, approximately 100 technical presentations and numerous ... international society for optics and photonics , the meeting ...
(Date:6/19/2013)... Adding to their already extensive supply ... Simport’s Dropette® and Heathrow Scientific disposable plastic ... basic biology, chemistry and any type of liquid handling ... 35 years, Simport has been supplying the science community ... the Simport Dropette®. Simport’s Dropette® is a one-piece ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... by the University of Wisconsin-Madison Lidar (Light Detection and Ranging) ... Cloud and Land Elevation Satellite) laser device. Lidars Arctic ... the test because it operates on the same wavelength as ... study the climate and changing polar ice sheets in the ...
... the team at Qurb (pronounced "curb"), I have to admit ... Not that the spam problem has been fundamentally and finally ... market, it simply seemed an improbable bet for an aspiring ... met the founders in 1997 when they were just building ...
... Model for High Performance ,Todays business conditions provide ... While the battles for talent might appear to have ... move beyond battlefield tactics to long-term winning strategies. ... in your overall talent strategy and fundamentally aligning your ...
Cached Biology Technology:UW-Madison Laser Device to Study Polar Ice Caps 2Qurb Gets a Step Up From Second-Time Entrepreneurs 2Qurb Gets a Step Up From Second-Time Entrepreneurs 3Qurb Gets a Step Up From Second-Time Entrepreneurs 4Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3
(Date:6/19/2013)... the Marine Biological Laboratory (MBL), Woods Hole, Massachusetts, ... by the American Society for Microbiology (ASM). ... and the scientists who worked there that have ... microbiology. A ceremony unveiling the plaque that ... June 22, 2013, at 4:30 pm in the ...
(Date:6/19/2013)... 2013 MedNet Solutions , a global ... systems, is pleased to announce its participation in the ... in Boston .  This represents the ... in cloud-based eClinical solutions, has exhibited at this premier ... iMedNet™ EDC , MedNet,s latest, easy-to-use eClinical ...
(Date:6/19/2013)... 2013  New York College of Health Professions announces ... and Trademark Office for detecting biometric changes through smart ... have been injured, attacked or killed. This ... Intellectual Properties Agreements of New York College of Health ... New York College says, "Our ...
Breaking Biology News(10 mins):Microbial diversity course designated as a 'Milestones in Microbiology' site 2MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4
... in the midst of a seething, breathing microbial world. ... from the surface of the human skin, to rainforest ... Despite the powerful and pervasive role of microbes ... a mystery. This is the subject of The Uncharted ...
... our previous beliefs, identical twins are not genetically identical. ... and Dutch scientists in a study being published today ... The finding may be of great significance for ... new diagnostic methods. How can it be that ...
... infection mechanism of bunyaviruses causing hemorrhagic fevers and ... from the University of Helsinki and structural biologists ... Max Planck Biochemistry Institute in Mnich has solved ... Uukuniemi virus is the first bunyavirus whose structure ...
Cached Biology News:Unexplored microbes hold incredible potential for science and industry 2Unexplored microbes hold incredible potential for science and industry 3The Uukuniemi virus helps to explain the infection mechanism of bunyaviruses 2
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
Biology Products: